The ubiquitous coenzyme nicotinamide adenine dinucleotide (NAD) decorates various RNAs in different organisms. In the proteobacterium Escherichia coli, the NAD-cap confers stability against RNA degradation. To date, NAD-RNAs have not been identified in any other bacterial microorganism. Here, we report the identification of NAD-RNA in the firmicute Bacillus subtilis. In the late exponential growth phase, predominantly mRNAs are NAD modified. NAD is incorporated de novo into RNA by the cellular RNA polymerase using non-canonical transcription initiation. The incorporation efficiency depends on the À1 position of the promoter but is independent of sigma factors or mutations in the rifampicin binding pocket. RNA pyrophosphohydrolase BsRppH is found to decap NAD-RNA. In vitro, the decapping activity is facilitated by manganese ions and singlestranded RNA 5 0 ends. Depletion of BsRppH influences the gene expression of $13% of transcripts in B. subtilis. The NAD-cap stabilizes RNA against 5 0 -to-3 0 -exonucleolytic decay by RNase J1.
, NAD-RNA has been found in yeast and mammalian cells (Walters et al., 2017; Jiao et al., 2017) . In E. coli, the NAD-cap decorates specific regulatory small RNAs (sRNAs) and sRNA-like 5 0 -terminal fragments of certain mRNAs (Cahová et al., 2015) . In mammalian cells, mRNAs and small noncoding RNAs were reported to be NAD capped (Jiao et al., 2017) , whereas in S. cerevisiae certain mRNAs carry the 5 0 modification (Walters et al., 2017) . The only verified mechanism for the biosynthesis of NAD-RNA is the incorporation of the native cofactor NAD by cellular RNA polymerases (RNAPs) during transcription initiation, having been shown for bacterial RNA polymerase in vitro and in vivo and for eukaryotic RNA polymerase II (Pol II) in vitro (Bird et al., 2016) . Factors that influence the incorporation of NAD into RNA by RNA polymerase are a matter of debate. The À1 position of the promotor functions as a key determinant of NAD-mediated initiation for certain transcripts in E. coli (Bird et al., 2016; Vvedenskaya et al., 2018) . Initiation factors do not seem to confer selectivity toward NAD incorporation into RNA. Furthermore, the rifampicin binding pocket of the b subunit of the RNA polymerase might be a structural determinant for the incorporation of NAD into RNA in E. coli (Julius and Yuzenkova, 2017) . Rifampicin binds to the b subunit of the RNA polymerase and inhibits transcription at the initiation stage (McClure and Cech, 1978) . During transcription, nucleoside triphosphates (NTPs) are in contact with and pass through this pocket. Mutations in the rifampicin binding pocket that conferred resistance were reported to concomitantly decrease the NAD incorporation efficiency of mutated RNA polymerases (Julius and Yuzenkova, 2017) .
Incorporation of NAD into RNA increases stability of the RNA against endonucleolytic degradation by RNase E in vitro in E. coli (Cahová et al., 2015) . Degradation of NAD-RNA was proposed to be triggered by the Nudix phosphohydrolase NudC (Frick and Bessman, 1995) , which decaps NAD-RNA into 5 0 -monophosphate RNA (p-RNA) and nicotinamide mononucleotide (NMN) (Cahová et al., 2015) . The conformation of the 5 0 end of the RNA plays a critical role for NudC-decapping activity, because it has to be single stranded and has to have a purine as the 5 0 -terminal nucleotide (Hö fer et al., 2016) . RppH, the RNA pyrophosphohydrolase known to remove pyrophosphate from the 5 0 end of ppp-RNA irrespective of the identity of the 5 0 -terminal nucleotide (Deana et al., 2008) , is impeded by the NAD-cap in vitro (Cahová et al., 2015) . Hence, two orthogonal pathways exist for the degradation of NAD-and ppp-RNA in E. coli. While the firmicute B. subtilis lacks an ortholog to NudC, BsRppH, the ortholog of RppH, is present and converts ppp-RNA into p-RNA and two orthophosphates, thereby triggering RNase J1-dependent degradation of the RNA (Richards et al., 2011) . In eukaryotic cells, a comparable stabilization of NAD-RNA against nucleolytic degradation has not been described to date. Instead, the non-canonical DXO/Rai1 decapping enzymes efficiently remove the entire NAD-cap, promoting 5 0 -to-3 0 decay of the RNA (Jiao et al., 2017) . To date, E. coli, a Gram-negative gut bacterium belonging to the phylum of proteobacteria, is still the only prokaryote for which specific NAD-capped RNAs were identified and for which capping and decapping mechanisms have been reported (Cahová et al., 2015; Hö fer et al., 2016; Bird et al., 2016) . It is unknown whether NAD capping exists in other phyla of the bacterial kingdom, which may differ strongly in many aspects of their biochemistry.
Here, we report the identification of NAD-RNA in the firmicute B. subtilis. NAD captureSeq enriched predominantly mRNAs, indicating that these RNAs are NAD capped. We show the incorporation of NAD into veg-mRNA by the cellular RNA polymerase in vivo. Transcription initiation with NAD is modulated by the À1 position of the promoter but is independent of the presence of a sigma factor or mutations in the rifampicin binding pocket. The NAD-cap can be specifically removed by BsRppH, resulting in p-RNA and NMN. The NAD-decapping activity is strongly enhanced by manganese ions and impaired by 5 0 -terminal double-stranded structures. In vivo, knockout of BsRppH does not lead to a global increase in NAD capping but instead upregulates the expression of $600 genes with diverse functions. Moreover, the NAD-cap stabilizes mRNA against exonucleolytic degradation by RNase J1 in a fashion similar to a 5 0 -terminal triphosphate group.
RESULTS

B. subtilis Contains NAD-Capped mRNA
An enzymatic assay, in combination with liquid chromatography coupled to mass spectrometry (LC/MS), was used to evaluate the occurrence of NAD-RNA in total RNA from B. subtilis (Figure S1A) . Total RNA was washed with urea to remove non-covalently bound NAD + ( Figure S1B ) and then treated with E. coli NudC, which decaps NAD-RNA, yielding 5 0 -p-RNA and NMN (Hö fer et al., 2016; Zhang et al., 2016) . The small-molecule fraction (containing NMN) was isolated and analyzed by LC/MS. We detected 6.3 ± 0.6 fmol of NAD-RNA per microgram of RNA, which corresponds to 220 ± 20 NAD-RNA molecules per B. subtilis cell, $14-fold lower than the value for E. coli (Chen et al., 2009) .
NAD captureSeq (Winz et al., 2017;  Figure S1C ) was then performed to isolate and identify the NAD-RNA species. Total RNA from B. subtilis of the late exponential phase ( Figure S1D ) was isolated without tRNA/rRNA depletion (three biological replicates) and either treated with ADP-ribosyl cyclase (ADPRC) or mock treated (minus ADPRC control). After biotinylation and capture of the previously NAD-capped RNAs on streptavidin beads, the RNAs were reverse transcribed into cDNA and amplified by PCR. The amplified libraries were purified on polyacrylamide gels (PAgels), whereby PCR products of between 150 and 300 bp were isolated ( Figure S1E ) and submitted to nextgeneration sequencing (NGS).
Plotting the log 2 fold change of the ADPRC-treated samples (Ss) versus the minus ADPRC controls (NCs) against the base mean of the RNAs from all samples revealed significantly enriched RNAs ( Figure 1A , green diamonds). Mainly mRNAs were found to be enriched. Evaluation of the distribution of mapped reads of the minus ADPRC control group showed that 95% accounted for tRNAs, 4% accounted for rRNAs, 1% accounted for mRNAs, and a few mapped to miscellaneous RNAs. In the ADPRC-treated sample group, the mRNAs accounted for 2% of the reads (compared with 93% accounted for by tRNAs and 5% accounted for by rRNAs) (Figures 1B and S1F) . Despite their high abundance, none of the tRNAs and rRNAs had an log 2 fold change R 1.1. The enriched RNAs were compared to the highest-expressed RNAs under comparable growth conditions (Nicolas et al., 2012) (Figure 1C ). Only 13 of 252 enriched RNAs are among the most abundant RNAs, indicating that a random incorporation of NAD into RNA by RNA polymerase is not probable. The reads of the enriched RNAs cluster at the 5 0 untranslated region (5 0 UTR)/5 0 end, which is in agreement with the principle of the NAD captureSeq protocol to capture NAD-RNAs 5 0 specifically . As expected, the reads of significantly enriched RNAs mostly start with an adenine (81%) ( Figure S2F , +1 position), which is consistent with the assumption of NAD incorporation by RNA polymerase. In most cases, the À1 nucleobase of the promoter is either a thymine (42%) or an adenine (31%). For nearly half of the enriched RNAs, the +2 position is occupied by a guanine, and at position +3, three of four enriched RNAs have purine bases. Functional clustering of the highest-enriched genes by NAD captureSeq resulted in eleven clusters (Figure S2G; see Discussion) .
To verify the calculated enrichment in the NGS dataset, qPCR analysis was performed with cDNA obtained after ligation of the second adapter, before PCR amplification ( Figures  1E and 1F ). For nine enriched mRNAs and three non-enriched RNAs, primers were designed that targeted the 5 0 end or the middle part of the gene. The 5 0 ends of all RNAs enriched in the NGS data were also enriched in qPCR (between 271 ± 36 [veg] and 24 ± 4 [gspA] fold) ( Figure 1F ). Moderate enrichment was calculated for the middle parts of the RNAs (between 64 ± 7 [phrE] and 3 ± 1 [gapB] fold). Northern blot analysis confirmed the full-length product for the veg mRNA (Figure S3A ). This finding contrasts the situation in E. coli, where mostly short 5 0 fragments were found to be NADylated (Cahová et al., 2015) .
To confirm that a NMN moiety is covalently attached to the 5 0 end of these RNAs, the abundant veg mRNA (Fukushima et al., 2003) (enriched) and 5S rRNA (not enriched) were isolated from total RNA by pull-down ( Figure S3B ), purified by PAGE ( Figures S3C and S3D ), and treated with NudC, and the small-molecule fraction was analyzed by LC/MS. For the isolated veg mRNA, a characteristic peak for the mass charge ratio (m/z) 122.81 ([M] + ), corresponding to nicotinamide (a fragment of N-ribosylnicotinamide [dephosphorylated NMN]), was detected in the extracted ion chromatogram ( Figure S3E ). In contrast, the peak was absent for the non-enriched 5S rRNA, which was still detectable by northern blot after the pull-down ( Figure S3F ).
RNA Polymerase Incorporates NAD into RNA by Noncanonical Transcription Initiation In Vitro
To assess whether NAD serves as initiator nucleotide for B. subtilis RNA polymerase, we performed in vitro transcriptions using DNA templates that composed part of the 5 0 upstream region, including the native promoter and a 75 nt long part of the transcribed sequence of enriched (Figures 1A and 1F) gapB and ctc genes, which are expressed under the control of sigma factor A (gapB; Gross et al., 1998) or sigma factor B (ctc; Igo and Losick, 1986) . Reactions were performed using the canonical nucleoside triphosphates and 32 P-NAD in the presence or absence of the sigma factors.
In both cases, we observed formation of full-length 32 P-NAD-RNA. Presence of the correct sigma factor increased the overall amount of transcribed RNA ( Figures S4A and S4B ).
To analyze whether the sigma factors promote specificity for NAD capping, in vitro transcription was performed in the presence of a-32 P-ATP, and non-radioactive NAD was added. The reaction products were analyzed on polyacrylamide gels supplemented with acryloylaminophenyl boronic acid (APBgels) (Igloi and Kö ssel, 1985) , which retards NAD-RNA (N€ ubel et al., 2017) . As expected for transcription of gapB, the presence of sigma A increased the transcription efficiency, while sigma B resulted in basal transcription (Figure S4C, left part) . NAD was incorporated by the RNA polymerase in all three cases, whereby the presence of sigma A did not increase the percentage of NAD-RNA (Figures S4C and S4E). The same trend was observed for transcription of ctc with the difference that sigma B stimulated RNA polymerase (Figures S4D and S4E) . The formation of NAD-RNA was confirmed by treating gapB RNA and ctc RNA with NudC (Hö fer et al., 2016) and the corresponding shift on APBgels ( Figure S4F ). To assess whether not only 5 0 -terminal fragments but also fulllength mRNAs are NAD capped by RNA polymerase, in vitro transcription reactions with nucleoside triphosphates and 32 P-NAD on templates containing part of the 5 0 upstream region, including the native promoter, the 5 0 untranslated region, and the entire coding sequence of veg, were performed. Veg plays a role in biofilm formation and is controlled by sigma A (Fukushima et al., 2003; Lei et al., 2013) . Full-length 32 P-NAD-veg mRNA was detected in elevated amounts with sigma A (Figure 2A ).
The À1 Position of the Promoter Influences the Incorporation of NAD into RNA In Vitro In E. coli, work indicates that the promoter sequence determines NAD incorporation efficiency by RNA polymerase (Bird et al., 2016; Vvedenskaya et al., 2018) . When we exchanged the thymidine at the À1 position of the veg promoter by adenosine, guanosine, or cytidine ( Figure 2B ), we observed a slight reduction ($-20%) of the total yield of in vitro transcribed veg mRNA that was sigma A independent ( Figure 2C ). When NAD was added to the reaction mixture (equimolar to ATP), the percentage of NAD-veg mRNA formed was found to depend on the À1 position, with G being most efficient (32%) and C being worst (16%) ( Figure 2D ). In the presence of sigma A, the same trend was observed. In all cases, more ppp-RNA was transcribed, indicating that ATP is preferred over NAD as the initiator nucleotide by the RNA polymerase. When NAD was used in four-fold excess over ATP, $10% more NAD-RNA was transcribed in the absence of sigma A for T, A, or G and $3% more was transcribed in case of C ( Figures S5A and S5B ), highlighting the negative effect of cytidine at the À1 position of the veg promoter. Incorporation of NAD into RNA was verified by treatment with NudC ( Figure S5C ).
Analogous experiments were performed with the sigma B-dependent ywjC gene. Here, the reduction of total transcript yield affected by mutations at the À1 nucleotide of the ywjC promoter position was larger (to about one-fifth) ( Figures S5D-S5F ), but the effect on NAD incorporation was comparable to the veg promoter ( Figures S5G and S5H ).
The À1 Position of the Promoter Influences the Incorporation of NAD into RNA In Vivo To investigate the effect of the À1 position of the promoter in vivo, a veg deletion mutant (B. subtilis Dveg) was complemented either with a plasmid-borne copy of wild-type veg (thymidine at the À1 position of its native promoter) or with veg-1C. Concomitantly, by complementation of Dveg with a medium-copy shuttle plasmid, the transcript number was increased to facilitate its detection. Total RNA was isolated from both strains and separated on an APBgel, and the veg mRNA was detected by a radioactive riboprobe ( Figure 3A ). NAD-veg mRNA was barely detectable in the wild-type ( Figure 3A , upper part, lane 1), but the increased abundance in the deletion strain complemented with veg and veg-1C enabled its detection ( Figure 3A , upper part, lane 3 and 5). The T-to-C transition decreased the amount of NAD-veg mRNA by around 40% from 3.6% ± 0.1% to 2.1% ± 0.1% ( Figure 3A , lower part, lanes 1-3 versus lanes 5-7, with quantification in Figure 3B ). The decrease in NAD-veg mRNA formation is in agreement with the findings observed in vitro ( Figure 2D ).
The Rifampicin Binding Pocket Does Not Foster Incorporation of NAD into RNA by RNA Polymerase Besides the influence of the À1 position of the promoter on non-canonical transcription initiation with NAD by RNA polymerase, the rifampicin binding pocket of the b subunit of the RNA polymerase has been reported to be influential in E. coli (Julius and Yuzenkova, 2017) . To investigate this phenomenon in B. subtilis, rifampicin-resistant mutants were generated. Mutations were introduced in the rifampicin binding site of B. subtilis 1A1 (wild-type) and a strain (1A774) with a Histagged b 0 subunit. Two of the mutant strains were used to express and purify their mutated RNA polymerases: RNAPrpoB-Q469I and RNAP-rpoB-H482Y ( Figure S5I ). For the homologous mutations in E. coli, Julius and Yuzenkova (2017) observed severely decreased NAD-to-ATP incorporation efficiencies (down to 15% of the wild-type incorporation). We tested the capability of both mutated polymerases, RNAPrpoB-Q469I and RNAP-rpoB-H482Y, to incorporate NAD into veg mRNA in vitro ( Figures 3C and 3D ). No differences were observed between the mutants and the wild-type. An increase of the NAD:ATP ratio to 4 to 1 with a simultaneous decrease of the reaction time readily increased the amount of NAD-RNA but did not result in any difference in activity between the RNA polymerase variants ( Figure 3E ). The finding was confirmed in vivo, because total RNA ( Figure S5J ) from B. subtilis 1A1 rpoB-Q469I (1.6 ± 0.5 fmol/mg total RNA) and B. subtilis 1A1 rpoB-H482Y (1.7 ± 0.7 fmol/mg) contained as much NAD-RNA as the wild-type (1.7 ± 0.5 fmol/mg, determined by the LC/MS assay described in Figure S1A ). BsRppH Decaps NAD-RNA In Vitro In E. coli, the 5 0 -NAD-cap stabilizes the RNA against RppH-triggered decay by RNase E in vitro, while its decay is induced by the Nudix hydrolase NudC by hydrolyzing the 5 0 -NAD into NMN and p-RNA (Cahová et al., 2015) . Among the seven Nudix hydrolases from B. subtilis, however, there is no NudC ortholog. In this organism, BsRppH, the ortholog of E. coli RppH (EcRppH), is known to initiate RNase J1-dependent decay by the sequential removal of two phosphate groups from 5 0 -ppp-RNA (Richards et al., 2011) . Because BsRppH has additionally been described as a multispecific (deoxy)nucleoside triphosphatase [(d)NTPase] (Ramírez et al., 2004), we tested this enzyme for its ability to decap NAD-RNA.
As model RNA, the veg mRNA was used, which is NAD capped in vivo ( Figures 3A and S3E) . In vitro transcribed 32 P-NAD-labeled veg mRNA with the 32 P (*p) at the penultimate phosphate (Np*pA-RNA) was incubated with BsRppH in the presence of either magnesium or manganese ions. Subsequently, the reaction mixture was treated by nuclease P1, which cleaves all phosphodiester bonds within an RNA and would release labeled AMP (*pA) if BsRppH has cleaved off NMN. The reaction products were resolved by thin-layer chromatography (TLC). BsRppH did release about 20% of NMN from NAD-veg mRNA in the presence of magnesium ions, as seen by a faint spot at the height of AMP (Figures 4A and 4E) . When the magnesium ions were exchanged by manganese, only one spot comigrating with AMP was detected, indicating the quantitative (>95%) removal of NMN from NAD-veg mRNA. With E. coli NudC, the same spot appeared ( Figure 4A ). Repetition of the reaction with NAD-veg mRNA, body labeled with a-32 P-ATP, revealed that the reaction is $2.5 times slower than the dephosphorylation of ppp-veg-mRNA by BsRppH ( Figures 4B, 4C , S6A, and S6B). BsRppH dephosphorylated ppp-veg-mRNA in the presence of magnesium and manganese with similar efficiency (Figures S6A-S6C ). When EcRppH was tested for its ability to decap NAD-vegmRNA, quantitative decapping was observed with magnesium or manganese ( Figure S6D ), and the rate of decapping in the presence of manganese was similar to that of BsRppHs (Figures 4B and 4C) . The activity of BsRppH was compromised by amino acid exchanges in the Nudix motif (Bessman et al., 1996) . Replacement of the catalytically important glutamate residues 68, 71, and 72 abolished enzymatic activity. Only the E68Q mutant showed some remaining decapping activity ( Figures 3D and S7A-S7D) . Hence, the Nudix motif is the catalytic center for the removal of NMN from NAD-RNA and of two phosphate groups from ppp-RNA.
BsRppH strictly requires a guanosine at the +2 position of the RNA for the dephosphorylation of transcripts (Hsieh et al., 2013; Piton et al., 2013) . 46% of the RNAs enriched by NAD captureSeq, among them the veg mRNA, fulfilled this criterion (Figure S2F ). To analyze whether the +2 position is also a determinant of NAD-RNA decapping, NAD-modified variants of the structurally defined 5S rRNA with three unpaired nucleotides at its 5 0 end and any of the four nucleotides at position +2 were Figure S5 . generated ( Figure 5A ). BsRppH decapped NAD-5S rRNA with a +2 guanosine about 2-to 3.5-fold more efficient than 5S rRNA variants with any of the other nucleosides occupying this position ( Figures 5B and 5C ). Thus, the substrate requirements for NAD decapping and dephosphorylation of RNA by BsRppH are similar but less strict with respect to position +2 of the RNA substrate. For efficient dephosphorylation, BsRppH requires at least two unpaired nucleotides at the 5 0 end and prefers three or more (Hsieh et al., 2013) . Assuming that this feature is also relevant for efficient decapping of NAD-RNA, BsRppH was tested on two NAD-5S rRNAs: NAD-5S rRNA, where only the adenosine of the 5 0 -NAD is not sequestered by base pairing in a doublestranded stem, and NAD-GU 5S rRNA, where a G and an U were appended to the 5 0 end, in addition to the NAD. Removal of the NMN moiety was severely impaired by the sequestered 5 0 end of the 5S rRNA, whereas the addition of two unpaired nu- Figures S1A and S1B translates into a total cellular concentration in the high nanomolar range, while free NAD is present at a low-millimolar concentration. To elucidate whether BsRppH maintains its NAD-RNA decapping activity under such conditions, NAD-veg mRNA was incubated with BsRppH in the presence of increasing amounts of NAD (1,000-fold or 10,000-fold excess). The NAD-RNA decapping activity of BsRppH was not compromised by NAD, which demonstrates the substrate preference of BsRppH in direct competition (Figures 6A and 6B Figure S7H ).
BsRppH Modulates Gene Expression in B. subtilis
BsRppH has been shown to influence the stability of primary 5 0 -triphosphorylated transcripts in vivo (Richards et al., 2011) . The observed decapping activity of BsRppH on NAD-RNA in vitro suggested that BsRppH may play an additional role in the turnover of NAD-mRNAs in vivo. Therefore, total RNA was isolated at different growth phases from wild-type B. subtilis, B. subtilis DmutTA, and B. subtilis DmutTA complemented with a chromosomal copy of mutTA and subjected to LC/MS analysis ( Figure S1A ) to determine the NAD-RNA content. Although the overall amount of NAD-RNA increased about four-fold in stationary (optical density 600 [OD 600 ] 2.0 + 3 hr) compared to lag phase (OD 600 0.5), the absence or presence of BsRppH did not affect the NAD-RNA amount ( Figure S7E ). Similar observations were made at the individual transcript level at which NAD modification of the veg transcript remained constant around 6.3% ± 1.1% (Figures S7F and S7G) .
To analyze the effects of BsRppH on gene expression in B. subtilis, transcriptome sequencing (RNA sequencing [RNAseq]) was carried out on total RNA isolated from B. subtilis and B. subtilis DmutTA harvested during exponential growth and depleted from rRNAs and tRNAs. 583 RNAs were significantly enriched (p val < 0.05, fold change > 2) (99% of which were mRNAs) in the DmutTA samples, indicating that BsRppH affects the gene expression of $13% of transcripts in B. subtilis (Figure 6C) . Functional analysis of the highest enriched gene products revealed five clusters ( Figure 6D ). Most relevant with regard to NAD-RNA metabolism is the cluster whose members play a role in redox processes and contain a nicotinamide adenine dinucleotide (phosphate) [NAD(P)] binding domain (cluster 1). None of the orthologous RNAs were likewise enriched in an EcRppH knockout (Deana et al., 2008) , consistent with the idea of the different functional scopes of the two enzymes. Roughly 80% of the transcripts highly increased in DmutTA are associated with general stress and are members of the sigma factor B (SigB) regulon ( Figure 6E ).
NAD-RNA Is Stabilized against Exonucleolytic Attack by RNase J1
In Vitro The removal of two phosphate groups of the yhxA-glpP and the DermC transcripts by BsRppH was reported to trigger their 5 0 -to-3 0 -exonucleolytic decay, catalyzed by RNase J1 (Richards et al., 2011) . RNase J1 is known to be impeded by a triphosphate group at the 5 0 end of RNA (Mathy et al., 2007) and appears to require 10 unpaired nucleotides at the 5 0 end for maximum 5 0 -exonucleolytic activity in vitro, in association with RNase J2 (Dorlé ans et al., 2011). To assess whether RNase J1's 5 0 -to-3 0 -exonucleolytic activity is affected by the NAD-cap, RNase J1 was purified ( Figure S7I ) and incubated with NAD-veg mRNA ( Figure 7 ). The veg mRNA might be a target of RNase J1/J2 in vivo, whereby the results are ambiguous (Durand et al., 2012; Mä der et al., 2008) . The NAD-cap stabilized the veg transcript against RNase J1 degradation but did so somewhat less efficiently than a 5 0 triphosphate. As expected, p-veg mRNA, the product of BsRppH activity, was accepted by RNase J1 and degraded.
DISCUSSION NAD Capping of RNA as a Ubiquitous Feature in Prokaryotes and Eukaryotes
The concept of 5 0 -capped RNAs being an exclusive and distinctive feature of eukaryotic gene expression was challenged by the discovery of RNAs modified with NAD in the Gram-negative proteobacterium E. coli (Cahová et al., 2015) . Here, we demonstrate that its Gram-positive counterpart, the firmicute B. subtilis, also contains NAD-RNAs but that these are different in nature and quantity. Around 14-fold less NAD-RNA was found for B. subtilis than for E. coli under comparable growth conditions (Chen et al., 2009) . For the NAD-RNAs discovered in yeast and mammalian cell lines, no quantification was reported (Walters et al., 2017; Jiao et al., 2017) . In B. subtilis, predominantly full-length mRNAs are NAD modified (Figures 1B and 1F) , which is different from the situation in E. coli, where mainly regulatory sRNAs and 5 0 fragments of mRNA with defined lengths were detected. No rRNAs and tRNAs were enriched in B. subtilis. All rRNA promoters from B. subtilis have been suggested to initiate with guanosine triphosphate (GTP) (Krá sný and Gourse, 2004), while RNAs identified by NAD captureSeq generally start with ATP (81%) (Figure S2F) . This may explain why rRNAs are generally not NAD modified at their 5 0 ends. tRNAs, particularly abundant in our dataset due to a missing depletion step ( Figure 1B The abundance of an mRNA in the cell does not correlate with its degree of NAD modification. Only around 5% of the 252 highest-expressed RNAs in a complex medium at the stationary phase (Nicolas et al., 2012) were enriched by NAD captureSeq ( Figure 1C ). This argues for a controlled process, rather than a random incorporation of NAD into RNA.
Functional clustering of the gene products of the most-enriched genes revealed that the molecular functions, biological processes, and cellular components to which the gene products of NAD-modified RNAs belong are highly diverse and that we cannot yet relate the NAD modification to a specific biological purpose. This analysis yielded eleven clusters, ranging from one with phosphoprotein phosphatase activity (cluster 1) to another with nucleotide binding properties (cluster 11) ( Figure S2G ). For some gene products, like L-threonine 3-dehydrogenase (tdh, belonging to clusters 4 and 7), which catalyzes an NAD + -dependent oxidation reaction, it is tempting to speculate that the cofactor NAD + may be replaced by NADtdh mRNA or that binding of the enzyme to its own mRNA may provide a regulatory feedback mechanism for its biosynthesis. However, more experimental work is needed to functionally link NAD-modified transcripts and their gene products. P-NAD, and the canonical nucleotides ( Figure 2A ). Fulllength mRNAs ( Figure 2A ) and sRNA-like 5 0 -terminal fragments of mRNAs ( Figure S4B ), as described for E. coli (Cahová et al., 2015) , were successfully generated in vitro. Biosynthesis of NAD-RNA by RNA polymerases is the only verified biosynthetic route (Jä schke et al., 2016) . We speculate that in prokaryotic organisms this might be the sole source of NAD-RNA, but in eukaryotes other mechanisms must be considered, because processed small nucleolar RNAs (snoRNAs) and small Cajal body RNAs (scaRNAs) have also been reported as NAD modified (Jiao et al., 2017) .
In our experiments, NAD-RNAs were identified in the late exponential growth phase or early stationary phase (Figures 1A and S1D). Two sigma factors, which mainly operate transcription at this phase, were tested for their influence on the incorporation of NAD into RNA, namely, the housekeeping sigma factor A (Gross et al., 1998) and the stress-related SigB (Hecker et al., 2007) . No statistically significant influence of these sigma factors on NAD incorporation could be measured. However, it is conceivable that some of the other 19 known sigma factors in B. subtilis modulate the efficiency of NAD incorporation into their RNA targets under different cellular conditions (Barvík et al., 2017; Julius and Yuzenkova, 2017) .
As in E. coli (Bird et al., 2016; Vvedenskaya et al., 2018) , the nucleotides around the TSS, in particular the À1 position of the promoter, influence the formation of NAD-RNA in B. subtilis in vivo and in vitro ( Figures 2D, 3A , and S5H). For the two RNAs investigated, the À1 position influences the formation of NAD-RNA in the following order: G > A z T > C, where G facilitates NAD-RNA formation and C represses it. This observation is in agreement with the À1 position being the crucial sequence determinant for NAD-RNA formation in E. coli, with G or A as the most preferred and C as the least preferred nucleotide or nu- cleotides (Vvedenskaya et al., 2018) . Only 9% of the promoters of NAD-RNA have a C at the À1 position ( Figure S2F ), suggesting that a high percentage of the NAD-modified state of a specific RNA is desired in the cell. For positions +2 and +3, we observed preferences similar to those in E. coli (Vvedenskaya et al., 2018) : +2G of 46% and +3A of 47%.
Under all studied competitive conditions, ATP is preferred over NAD for transcription initiation, as seen for E. coli (Vvedenskaya et al., 2018) . The total cellular concentration of ATP and NAD does not seem to be the major determinant of their incorporation. Nonetheless, local intracellular accumulation of NAD might foster the formation of NAD-RNA (Barvík et al., 2017) .
During transcription initiation, the 5 0 end of nascent transcripts is in contact with amino acids that, when exchanged, confer resistance toward rifampicin. The rifampicin binding site is part of the b subunit of the RNA polymerase and conserved between E. coli and B. subtilis (Ingham and Furneaux, 2000) . Several amino acid exchanges in the rifampicin pocket have been described to decrease the NAD incorporation efficiency into dinucleotides (Julius and Yuzenkova, 2017) . Two B. subtilis RNA polymerase mutants, RNAP-rpoB-Q469I and RNAPrpoB-H482Y, whose E. coli homologs were reported to have severely ($90%) and moderately ($40%) decreased NAD incorporation efficiency, showed no altered NAD incorporation into veg mRNA (Figures 3C-3E) . Hence, the effect on NAD-RNA formation of mutations in the rifampicin binding site of the RNA polymerase is ambiguous and needs further investigation. It is conceivable that other sigma factors may induce conformational changes of the core RNA polymerase that modulate rifampicin resistance (Wegrzyn et al., 1998) and perhaps NAD incorporation efficiency.
The Nudix Hydrolase BsRppH Decaps NAD-RNA The existence of NAD-RNA demands the presence of enzymes capable of removing the 5 0 cap. We found RNA pyrophosphohydrolase BsRppH to efficiently decap NAD-RNA into p-RNA and NMN (Figure 4) S6D ). This latter finding suggests that EcRppH (like BsRppH and NudC) has strong, unknown, sequence and/or structure preferences; as with highly structured E. coli RNAI, only slow NAD-RNA decapping ($60-fold reduced, compared to ppp-RNA dephosphorylation) was observed (Cahová et al., 2015) . From mutational analysis, we conclude that the Nudix motif (Bessman et al., 1996) is the catalytic center and that the glutamate residues 71 and 72 are particularly important for the catalytic activity of BsRppH ( Figures 4D and S7C ). The Nudix motif is also the active center for the removal of the g-and b-phosphate from ppp-RNA (Richards et al., 2011) . In BsRppH, Glu72 and Gly54 coordinate one Mg 2+ ion, whereas Glu68, Glu72, and
Glu115 coordinate the second. The Mg 2+ ions are important for the coordination of the g-phosphate (Piton et al., 2013) . Hence, Glu71 might only be involved in the binding of Mn 2+ and the subsequent cleavage of the phosphoanhydride bond of NAD. In E. coli, the homologous glutamate residues Glu174 (Glu68 in BsRppH) and Glu178 (Glu72 in BsRppH) are known to be important in this reaction (Hö fer et al., 2016; Zhang et al., 2016) , whereas a NudC-Glu177Ala mutant (Glu71) retained about 50% of its decapping activity (Zhang et al., 2016) . Altogether, a high-resolution structure of BsRppH bound to NAD-RNA or an NAD dinucleotide in the presence of Mg 2+ or Mn 2+ ions will be indispensable to clarify the change in specificity.
Crucial for removal of the g-and b-phosphates from ppp-RNA by BsRppH are the presence of a guanine at the +2 position of the mRNA and at least 2 unpaired nucleotides at the 5 0 end (Hsieh et al., 2013; Piton et al., 2013) . We find that both criteria apply less strictly to NAD-RNA decapping by the same enzyme as RNAs with A, C, or U are processed, albeit 2-3.5 times slower than G ( Figures 5B and 5C ), and decapping of a 5 0 -doublestranded NAD-5S rRNA was accelerated over background (Figure 5D) , in contrast to the data reported for dephosphorylation (Hsieh et al., 2013) .
The role of BsRppH in vivo remains enigmatic, a phenomenon quite common for the family of Nudix hydrolases (McLennan, 2013) . Originally described as a multispecific (d)NTPase (Ramírez et al., 2004) , it was later suggested to remove two phosphates from primary transcripts, but in vivo data remained controversial. It has been proposed that an additional RNA dephosphorylating enzyme with redundant activity exists (Richards et al., 2011) , but the search for this enzyme remained unsuccessful. For orthologous EcRppH, evidence suggests that in vivo this enzyme might not process ppp-RNA and that its major function is the dephosphorylation of pp-RNA (Luciano et al., 2017) , a species that is largely unknown. Thus, our current understanding of BsRppH's role in mRNA turnover may be wrong. The BsRppH knockout mutant did not show increased NAD modification under the investigated conditions, contrary to what was observed for NudC in E. coli, which might be due to a redundant enzyme.
Whether the observed effects of BsRppH knockout on gene expression are due to an influence on NAD decapping or capping cannot be inferred from our data. Upregulation of the expression of stress-related genes in BsRppH-depleted cells might be due a combination of the increased stability and hence the accumulation of a variety of transcripts and the accumulation of mutations in DNA and RNA.
The observed stabilization of NAD-veg mRNA against RNase J1 degradation (Figure 7) suggests that similar to 5 0 -triphosphorylated transcripts, NAD-capped RNAs first needs to be processed (e.g., by BsRppH) to induce their turnover. Hence, certain transcripts can be stabilized by the NAD-cap, which may be interesting when the gene expression pattern changes and RNA recycling increases (Barvík et al., 2017) .
Outlook
The identification of NAD-RNA in B. subtilis adds to the growing number of organisms harboring this type of RNA modification. To date, NAD-RNAs have been found in all domains of life except archaea. Many classes of RNAs have been found to be decorated by a 5 0 -NAD. Some of them, like the sno or scaRNAs (Jiao et al., 2017) , are 5 0 -processed transcripts, which implies that there is an alternative biosynthetic route than incorporation of NAD by cellular RNA polymerases. The increase in stability of NAD-RNAs against exonucleolytic decay will likely not be the sole biological function of this type of RNA modification (Jä schke et al., 2016) . In particular, NAD-using enzymes with a RNA binding domain whose transcripts are NAD modified might catalyze reactions in the presence of the RNA-bound cofactor. It also remains to be investigated how the activity of BsRppH is modulated by Mn 2+ in vivo to switch from the dephosphorylation of primary transcripts to NAD-RNA decapping. This leads to the interesting question of how the Mn 2+ homeostasis influences the global NAD-RNA level in B. subtilis.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Growing cells for RNA extraction Saturated cultures of B. subtilis in LB broth (Lennox) medium were diluted into fresh LB medium (supplemented with antibiotics were indicated) to an initial OD 600 of 0.1 and shaken at 37 C until the OD 600 reached 0.5, 1, 2 or 2 following 3 h of further cultivation. 
METHOD DETAILS Strains
Bacillus subtilis 168 (Bacillus Genetic Stock Center ID: 1A1) was used as a wild-type strain. For purification of the RNA polymerase, B. subtilis 168 (BGSCID: 1A774) with a His 6 -tagged b' subunit (rpoC) was used. All strains are listed in the Key Resources Table. Bacillus subtilis 1A1 and Bacillus subtilis 1A774 were used for the generation of the RNAP-rpoB-H482Y and RNAP-rpoB-Q469I mutants. Genomic DNA from B. subtilis 168 was used to amplify (Q5 Hot Start High-Fidelity DNA Polymerase, NEB) two overlapping regions ($300 bp) of rpoB. For the H482Y (Q469I) exchange, the primer pairs Fwd-5 0 -rpoB/Rev-5 0 -H482Y (Fwd-5 0 -rpoB/Rev-5 0 -Q469I) and Fwd-3 0 -H482Y/Rev-3 0 -rpoB (Fwd-3 0 -Q469I/Rev-3 0 -rpoB) were used (Table S1 ). The two PCR products were combined by joining PCR using Fwd-5 0 -rpoB/ Rev-3 0 -rpoB resulting in PCR products of 640 bp. The purified PCR products were used to transform Bacillus subtilis 1A1, and Bacillus subtilis 1A774, respectively (Koo et al., 2017) . The cells were plated on LB agar containing 50-200 mg/ml rifampicin (Sigma-Aldrich). From single colonies, genomic DNA was isolated, the rpoB region amplified by PCR and the mutation verified by sequencing. The resulting strains Bacillus subtilis 1A1 rpoB-H482Y and Bacillus subtilis 1A1 rpoB-Q469I were used to isolate total RNA. From Bacillus subtilis 1A774 rpoB-H482Y and Bacillus subtilis 1A774 rpoB-Q469I the cellular RNAP was isolated and purified.
Bacillus subtilis BKE00440 with a chromosomal deletion of veg was complemented with a plasmid-borne copy of wild-type veg or veg with a T to C transition at position À1 of the promoter (veg-1C). The plasmids pHT01-P veg -veg and pHT01-P veg-1C -veg, respectively, were transformed into Bacillus subtilis BKE00440. The cells were plated on LB agar containing 5 mg/ml chloramphenicol (Sigma-Aldrich). The resulting strains Bacillus subtilis BKE00440-pHT01-P veg -veg and BKE00440-pHT01-P veg-1C -veg were grown in LB medium supplemented with 5 mg/ml chloramphenicol and 1 mg/ml erythromycin (Sigma-Aldrich) to isolate total RNA.
Bacillus subtilis BKE30630 with a chromosomal deletion of mutTA (encodes for BsRppH) was complemented with a chromosomal copy of the wild-type mutTA at the amyE locus. The mutTA complementation DNA fragment was generated by joining PCR of three fragments: mutTA, 5 0 -amyE DNA fragment and 3 0 -amyE DNA fragment including cat (chloramphenicol resistance). mutTA was amplified from genomic DNA from B. subtilis 168 using the primer pair Fwd-mutTA/Rev-mutTA. The 5 0 -and 3 0 -amyE DNA fragments were amplified from pBS1C (Addgene plasmid #55168; pBS1C was a gift from Thorsten Mascher (Radeck et al., 2013)) using the primer pairs Fwd-amyE-5 0 /Rev-amyE-5 0 and Fwd-amyE-3 0 /Rev-amyE-3 0 , respectively. The three purified DNA fragments, mutTA (100 ng), 5 0 -amyE DNA fragment (50 ng), and 3 0 -amyE DNA fragment (50 ng), were mixed and subjected to the joining PCR in the presence of Fwd-amyE-5 0 and Rev-amyE-3 0 resulting in a PCR product of 3460 bp. The purified joined PCR product was used for transformation of Bacillus subtilis BKE30630. The cells were plated on LB agar containing 5 mg/ml chloramphenicol. From a single colony, genomic DNA was isolated, mutTA integrated at the amyE locus amplified by PCR and the insertion verified by sequencing. The resulting strain Bacillus subtilis BKE30630 mutTA was used to isolate total RNA.
Bacillus subtilis 1A1, BKE30630 and BKE30630 mutTA were transformed with pHT01-P veg -veg (kan R ). The cells were plated on LB agar containing 10 mg/ml kanamycin (Carl Roth). The resulting strains Bacillus subtilis 1A1-pHT01-P veg -veg (kan R ), BKE30630-pHT01-P veg -veg (kan R ) and BKE30630 mutTA-pHT01-P veg -veg (kan R ) were grown in LB medium supplemented with 30 mg/ml kanamycin to isolate total RNA.
Plasmid construction
The genes of the sigma factor A (sigA) and sigma factor B (sigB), BsRppH (mutTA) and RNase J1 (rnjA) were amplified from genomic DNA from B. subtilis 168. XbaI and XhoI restriction sites were introduced during PCR amplification with the primers Fwd-SigA/Rev-SigA, Fwd-SigB/Rev-SigB, Fwd-BsRppH/Rev-BsRppH, and Fwd-RNase J1/Rev-RNase J1 (Table S1 ). The amplified PCR products were treated with XbaI and XhoI and cloned into pET-28a(+) (Novagen) resulting in the plasmids pET-28a-SigA, pET-28a-SigB, pET-28a-BsRppH and pET-28a-RNase J1. All mutants of BsRppH and RNase J1 were generated by site-directed mutagenesis. The primer for the introduction of the respective mutations are listed in Table S1 . The resulting linearized plasmids pET-28a-BsRppH-E68Q, -E71Q, -E72Q, -E68Q-E71Q, -E68Q-E72Q, -E71Q-E72Q, and pET28a-RNase J1-H76A were ligated (T4 DNA ligase, Thermo Scientific). The plasmids pET-28c-NudC, pET-28c-NudC-V157A-E174A-E177A-E178A (NudC-M1), and pET-28c-NudE from E. coli were a kind gift of K. Hö fer. pET-28c-NudE-E99Q was generated as described in Hö fer et al. (Hö fer et al., 2016) using the primers Fwd-NudE-E99Q/Rev-NudE-E99Q.
The cloning of pHT01-P veg -veg and pHT01-P veg-1C -veg was performed in two steps. veg was amplified from genomic DNA from B. subtilis 168 using the primers Fwd-veg(À1C)-Gib/Rev-veg-Gib introducing an overlap to the plasmid Pveg. The plasmid Pveg (Addgene plasmid #55173; Pveg was a gift from Thorsten Mascher (Radeck et al., 2013)) was amplified using the primers FwdPveg/Rev-Pveg(À1C). Both linear PCR products were combined using the method (One-step isothermal DNA assembly) described by Gibson et al. (Gibson et al., 2009 ) resulting in the plasmids Pveg-veg and Pveg-1C-veg. Pveg-veg and Pveg-1C-veg served as template to amplify veg with its native promoter with the primers Fwd-veg-BamHI/Rev-veg-XbaI. The primers introduced a BamHI and a XbaI restriction site, respectively. The resulting PCR product and pHT01 (MoBiTec) were digested with BamHI/XbaI and ligated, yielding pHT01-P veg -veg and pHT01-P veg-1C -veg.
In order to exchange the chloramphenicol-resistance cassette (cm R ) in pHT01-P veg -veg to a kanamycin-resistance cassette (kan R ), the kan R gene was amplified with the primers Fwd-kanR/Rev-kanR from pGP888 (Diethmaier et al., 2011) . The plasmid pHT01-P veg -veg was amplified using the primers Fwd-pHT01-veg-gib/Rev-pHT01-veg-gib. Both linear PCR products were treated with DpnI (Thermo Scientific), gel purified and combined using the method (One-step isothermal DNA assembly) described by Gibson et al. (Gibson et al., 2009 ) resulting in the plasmid pHT01-P veg -veg (kan R ). All plasmids are listed in the Key Resources Table. Protein expression and purification The expression and affinity purification of NudC, NudE (-E99Q), BsRppH (mutants), and RNase J1 (-H76A) were performed as described (Cahová et al., 2015) with minor changes. HisTrap buffer A (50 mM Tris-HCl pH7.5, 0.3 M NaCl, 5 mM MgSO 4 , 5 mM 2-mercaptoethanol, 5% glycerol, 5 mM imidazole, 1 tablet per 1 l complete EDTA-free protease inhibitor cocktail (Sigma-Aldrich)) and HisTrap buffer B (HisTrap buffer A with 500 mM imidazole) were used. For the purification of sigma factor A and sigma factor B, E. coli harboring the respective plasmid were induced in between OD 600 0.6-08 with 0.1 mM IPTG. The cells were chilled for 30 min at 4 C and incubated at 17 C for 17 h. The purification by affinity chromatography was performed as described (Cahová et al., 2015) . Fractions containing the protein of interest were concentrated in a centrifugal filter (10 kDa MWCO, Amicon, Merck) and the buffer exchanged to Buffer G (50 mM Tris-HCl pH7.5, 300 mM NaCl, 0.1 DTT). For further purification, size-exclusion chromatography was performed using a Superdex 200 10/300 GL column in Buffer G. The purity of all proteins was analyzed by SDS-PAGE (Coomassie staining) and the concentration determined by a BCA protein assay (Life Technologies). For the purification of the cellular RNAP from B. subtilis and its mutants, Bacillus subtilis 1A774, Bacillus subtilis 1A774 rpoB-H482Y, and Bacillus subtilis 1A774 rpoB-Q469I were grown at 37 C with shaking at 150 rpm in LB broth (Lennox) medium to an OD 600 1.2. The cells were harvested by centrifugation, solved in 30 mL Base stock solution/5 mL cell pellet (20 mM Tris-HCl pH7.8, 10 mM MgCl 2 , 100 mg/ml lysozyme (Sigma-Aldrich), 5 ml Benzonase Nuclease (R250 units/ml, Sigma-Aldrich), 1 tablet complete EDTA-free protease inhibitor cocktail (Sigma-Aldrich)), and incubated on ice for 30 min with periodic vortexing. Cell lysis was performed using a cell disrupter at 2.1 kPa pressure (Constant Systems Ltd.). The RNAP was purified from the cell lysate was described (Cahová et al., 2015) . The proteins were solved in Buffer G' (Tris-HCl pH7.8, 300 mM NaCl, 0.1 DTT). All proteins were stored in 50% glycerol at À20 C. NudC which was used for the treatment of total RNA for subsequent UPLC/MS measurement was purified as described above but NaCl was exchanged by NH 4 Cl. In addition, aliquots of the protein were flash frozen and stored without glycerol.
NAD captureSeq, RNA-seq Next-generation sequencing (NGS) and data analysis For the identification of NAD-RNA from B. subtilis 1A1 total RNA, NAD captureSeq was performed as described in Winz et al. (Winz et al., 2017) . PCR products in a size range of 150 bp to 300 bp were purified by polyacrylamide gel electrophoresis. The removal of primer dimers was evaluated by a Bioanalyzer measurement (Bioanalyzer 2100, Agilent) using the Agilent DNA 1000 Kit (Agilent). The multiplexed library was submitted to NGS using single-end reads, 75-bp read length, read depth 400 million on the NextSeq500 (Illumina) platform. 20% PhiX control DNA was spiked into the sample to provide sufficient read complexity. Bioinformatic analysis of the NGS data was performed with an in-house pipeline. In brief, starting Gs of the raw reads were trimmed and the 3 0 -adaptor was clipped. Processed reads (R18 nt) were mapped to the reference genome Bacillus subtilis subsp. subtilis str. 168 (ENA, Assembly: GCA_000009045.1) using Bowtie (version: 1.1.2, Langmead et al., 2009; mismatch % 2) . Multiple mapped reads with the same match score were randomly distributed. After strand-specific screening, HTSeq (version: 0.6.0, Anders et al., 2015) was used to count gene hits. Statistical analysis was performed with DESeq (Anders and Huber, 2010). The Integrated Genome Browser (Nicol et al., 2009 ) was used to inspect and visualize candidate sequences. Functional cluster analysis was performed using DAVID (Huang et al., 2009) and FGNet (Aibar et al., 2015) .
RNA-seq was performed using B. subtilis 1A1 and B. subtilis BKE30630 total RNA harvested during exponential growth (OD 600 0.5). Ribosomal RNA (Ribo-Zero rRNA Removal Kit (Gram-Positive Bacteria), Illumina) was depleted from biological triplicates (4.5 mg input material/sample) of each strain. cDNA and library preparation was performed with the NEBNext Ultra II Directional RNA Library Prep Kit for Illumina (NEB) in conjunction with the NEBNext Multiplex Oligos for Illumina (NEB). Modifications to the standard protocol were, 10 min at 94 C for fragmentation, 30 min at 42 C for first strand synthesis, and 2 h at 16 C for second strand synthesis. 12 cycles PCR was performed. Agencourt AMPure XP RNA Clean beads (Beckman Coulter) were used to remove excessive primer and primer dimers. Samples were quantified with the Qubit HS DNA (Thermo Scientific) reagents, and quality controlled with the Tape Station D1000 for DNA reagents (Agilent). Samples were then equimolar pooled using size determination from the Tapestation and concentration from the Qubit. Sequencing was 75 SE on the Illumina NextSeq 500 system. Bioinformatic analysis of the NGS data was performed with an in-house pipeline.
Quantitative PCR
To validate the enrichment of the RNAs observed in the NGS data on cDNA level, quantitative PCR (qPCR) was performed as described earlier (Cahová et al., 2015) . In brief, reactions were performed in 20 ml scale in duplicate with 3 ml cDNA (1:50 diluted) as template. qPCR was performed in a Light Cycler 480 instrument (Roche) using the Brilliant III Ultra-Fast SYBRGreen qPCR Mastermix (Agilent). The data was analyzed with the Light Cycler 480 Software (Agilent). The 2 -DDC T -method (Livak and Schmittgen, 2001 ) was used to compare APDRC-treated sample cDNA with cDNA of the minus ADPRC control. Millipore water was used as a negative control and tRNA Ile as internal control gene. Primer efficiency was determined with serial dilutions of cDNA obtained by reverse transcription of total RNA (3 mg) using random hexamers (Jena Bioscience) and SuperScript IV reverse transcriptase (Thermo Scientific) following the manufacturer's instructions. The determined C p-value s were plotted against the dilution factor. The efficiency E was determined with the formula E = 10 -1/slope . The primers used for qPCR analysis are listed in Table S1 .
UPLC/MS analysis
For the detection of NAD covalently bound to RNA in total RNA isolates, the RNA was loaded on a centrifugal filter (10 kDa MWCO, Amicon, Merck) washed three times with 400 ml 8.3 M urea, one time with Millipore water, two times with 4.15 M urea and again four times with Millipore water. The RNA was recovered from the filter, concentrated under reduced pressure and treated with NudC. Reactions were performed on a 10 ml scale in 10 mM MgCl 2 , 0.6 ng/ml d4-riboside nicotinamide (Toronto Research Chemicals, internal standard) and 0.05 U/ml alkaline phosphatase (Sigma-Aldrich) at 37 C for 1-2 h (2 h for pull-down RNA). 10 mg urea-washed total RNA were mixed with 10 mM NudC, or inactive NudC-M1. After the reaction, the reaction mixture was filtered through a centrifugal filter (10 kDa MWCO). The filter was washed four times with 200 ml water and the filtrate was dried under reduced pressure. UPLC/MS/MS experiments were performed on a triple stage quadrupole mass-spectrometer (Waters, Xevo TQ-S) system coupled with an Acquity UPLC System. A BEH Amide column (1.7 mm, 2.1x50 mm) was used at a flowrate of 0.8 ml/min using an eluent consisting of 0.01% (vol) aqueous formic acid with 0.05% ammonia and 5% acetonitrile (A) and acetonitrile including 0.01% formic acid (B). The gradient started with 12.5% A/ 87.5% B. The ratio was changed (0.0 min to 1.8 min) to 95% A/ 5% B. Within the next 1.0 min the ratio returned to starting conditions. The column was equilibrated for 1 min under starting conditions. ESI was used with a capillary voltage of 1,500 V, cone voltage of 11 V, source temperature of 150 C, desolvation temperature of 200 C, cone gas flow (N 2 ) of 150 l/h, desolvation gas flow (N 2 ) of 800 l/h. The Xevo TQ-S was tuned automatically to d4-nicotinamide riboside and nicotinamide riboside using MassLynx V4.1 system software (Waters) and the IntelliStart standard procedures. Multiple reaction monitoring (MRM) measurements were performed using argon as collision gas at 0.15 ml/min for collision induced decomposition ( A calibration curve was recorded for N-ribosylnicotinamide for each analytical batch. The peak areas of the analyte and internal standard were calculated by using the TargetLynx software. The ratio of the analyte to the internal standard was calculated and the amount of injected nicotinamide riboside could be determined using the calibration curve. NAD-RNA molecules per cell were calculated as described by Chen et al. (Chen et al., 2009 ).
Total RNA isolation Three methods were used to isolate total RNA from Bacillus subtilis: either the method described by Bechhofer et al. (Bechhofer et al., 2008 ; RNA isolation protocol 2), the method described by Stead et al. (Stead et al., 2012) or the hot acidic phenol-chloroform method were used. For the latter, bacteria were grown at 37 C with shaking at 150 rpm in LB broth medium until an OD 600 z2. 100 mL culture were mixed with 12.5 mL stop solution (95% ethanol, 5% water-saturated phenol) and harvested by centrifugation at 3,000 g at 4 C for 15 min. The cell pellet was resuspended in 10 mL TES solution (10 mM Tris-HCl pH 7.5, 10 mM EDTA, 0.5% SDS), sonicated (30 s, 50% power, three times) and 10 mL phenol/chloroform/isoamylalcohol (P/C/I, 125:40:1) were added, mixed and incubated for 10 min at 65 C with shaking at 750 rpm. The suspension was centrifuged at 11,000 g at 4 C for 1 h. The aqueous phase was recovered and the extraction repeated with Aqua-P/C/I (Carl Roth) until the aqueous phase was clear. Residual P/C/I was removed by chloroform extraction and the total RNA was ethanol precipitated. To remove residual genomic DNA, the RNA was treated with DNase I ($1.5 U/mg total RNA, Sigma-Aldrich) at 37 C for 45 min, P/C/I-chloroform-extracted and precipitated. The RNA was washed twice with 75% ethanol and solved in Millipore water.
Gel electrophoresis and Northern blot analysis
Classical polyacrylamide gel electrophoresis (PAGE) was used to separate RNA. PCR-amplified cDNA libraries for NGS were purified by native PAGE ( Figure S1E ). For the discrimination of NAD-RNA and ppp-/p-RNA, polyacrylamide (PA) gels supplemented with acryloylaminophenyl boronic acid (APBgel) were used (N€ ubel et al., 2017) . Northern blot analysis was performed as previously described (Cahová et al., 2015) with minor changes. RNA was separated on PA or APBgels (5 W, 90 min) and transferred by electroblotting to a Whatman Nytran SuPerCharge nylon blotting membrane (Merck) for 2.5 h (4 h for APBgels) at 250 mA and crosslinked by UV light. Membranes were prehybridized in ULTRAhyb Ultrasensitive Hybridization Buffer (Thermo Scientific) for 2 h at 48 C and 5 ml riboprobe (Table S1 ) added and incubated overnight at 48 C. Templates for the riboprobes were prepared by PCR using Taq DNA polymerase (laboratory prepared stock). Riboprobes were prepared by in vitro transcription in the presence of 35 mCi a-32 P-ATP and 35 mCi a-32 P-CTP (3,000 Ci/mmol, each, Hartmann Analytic). The RNA was treated by DNase I (Sigma-Aldrich), P/C/I-chloroformextracted, isopropanol-precipitated and dissolved in 50 ml Millipore water. The blot was washed for 30 min with wash solution 1 (2x SSC, 0.1% SDS) and for 30 min with wash solution 2 (0.25x SSC, 0.1% SDS). RNA size standards (RNA Century Marker Templates (Thermo Scientific)) were in vitro transcribed using T7 RNA polymerase in the presence of 35 mCi a-32 P-ATP. Size standards for the Northern blot analysis were prepared by in vitro transcription reactions. Linear DNA templates were prepared by PCR using Q5 Hot Start High-Fidelity DNA Polymerase (NEB) and the oligonucleotides listed in Table S1 . PCR mixtures contained 50 ng genomic DNA from B. subtilis 1A1 and 0.5 mM of the respective forward and reverse primers. PCR products were purified before they were used in the transcription reactions. The primer combination for the preparation of the veg mRNA used in Figures 3A and S7F was Fwd-T7-veg/Rev-veg.
Preparation of radiolabeled ppp-, p-and NAD-RNA by in vitro transcription, ABPgel analysis, and Phosphorimaging In vitro transcription was performed as described by Huang (2003) with minor modifications: 1-1.5 mg/100 ml reaction doublestranded DNA (dsDNA) template in transcription buffer (40 mM Tris-HCl pH 8.1, 1 mM spermidine, 22 mM MgCl 2 , 0.01% Triton X-100, 10 mM dithiothreitol (DTT), 5% DMSO), along with 4 mM NTPs, with 6 mM NAD (NAD-RNA; ATP concentration was halved to 2 mM) or without NAD (ppp-RNA) was mixed in a reaction tube. Table S1 lists the primer used for the preparation of the DNA templates. For radiolabeling (bodylabel for ppp-RNA or NAD-RNA, respectively) 100 mCi/100 ml reaction a-32 P-ATP (3,000 Ci/mmol, Hartmann Analytic) were added to the reaction. For 5 0 -labeling ( 32 P-NAD-RNA) 50 mCi/100 ml reaction 32 P-NAD (800 Ci/mmol, Perkin Elmer) were added. Then 5 ml/100 ml reaction T7 RNA polymerase (1 mg/ml, laboratory prepared stock) was added and the reaction mixture incubated at 37 C for 3-4 h. For the preparation of radioactive monophosphorylated RNA (p-32 P-RNA), transcription was performed as described above, following dephosphorylation by 0.1 U/ml alkaline phosphatase (Thermo Scientific) and labeling with T4 polynucleotide kinase (Thermo Scientific) and 100 mCi g-32 P-ATP (3000 Ci/mmol, Hartmann Analytic) following the manufacturer's instructions. The transcription was stopped by the addition of gel loading buffer (for purification over PAgels: 10% TBE in formamide containing 0.05% bromophenol blue, 0.5% xylene cyanol blue; for APB gels: 8 M urea, 10 mM Tris-HCl pH 8.0, 50 mM EDTA containing xylene cyanol and bromophenol) and purified over either an 8% PAgel, or an APBgel (N€ ubel et al., 2017) containing 5% acrylamide and 0.4% APB using standard electrophoresis conditions (PAgel: 1x TBE buffer, 20 W; APBgel: 1x TAE buffer, 10 W). RNAs were excised and eluted in 0.3 M sodium acetate (pH 5.5) overnight at 19 C. The eluted RNA was precipitated with isopropanol and dissolved in Millipore water. Radioactive RNA or nucleotides on gels, or thin-layer chromatography plates were visualized using storage phosphor screens (GE Healthcare) and a Typhoon FLA 9500 imager (GE Healthcare), quantified using ImageQuant software (GE Healthcare) and plotted using OriginPro software (OriginLab).
Specific isolation of (''pull-down'') of veg mRNA and 5S rRNA RNAs were specifically isolated from total RNA as described previously (Cahová et al., 2015) with minor changes. 150 ml streptavidin agarose slurry were loaded to Mobicol Classic columns (MoBiTec), washed three times with 1x PBS and biotinylated DNA probes (biomers ; Table S1 ) dissolved in 1x PBS (three times 25 ml á 25 mM with incubation for 10 min at 25 C with shaking at 500 rpm) were added. After washing and equilibration of the beads (three times with 1x PBS and 1x pull-down buffer (10 mM Tris-HCl pH 7.8, 0.9 M tetramethylammoniumchloride, 0.1 M EDTA pH 8.0), 300 mg total RNA dissolved in 1x pull-down buffer were added. First, the RNA was incubated for 10 min at 65 C and then for 25 min at 20 C while rotating (Tube Rotator, VWR). To remove unbound RNA, the slurry was washed six times with Millipore water. To elute the RNA, four times 2 mM EDTA (200 ml, pre-heated to 75 C) were added and the RNA incubated for 10 min at 75 C with shaking at 350 rpm for 10 s every minute. The eluate was concentrated under reduced pressure and precipitated with 0.5 M ammonium acetate and isopropanol in a reaction tube. The precipitated RNA was dissolved in Millipore water and further purified by 8% PAGE. The purified RNA was used for Northern bot analysis or treated with NudC/-M1 and applied for UPLC/MS analysis as described earlier.
In vitro transcription with B. subtilis RNAP: linear template preparation Linear templates for the in vitro transcription reactions were prepared by PCR using Q5 Hot Start High-Fidelity DNA Polymerase (NEB) and the oligonucleotides listed in Table S1 . PCR mixtures contained 50 ng genomic DNA from B. subtilis 1A1 and 0.5 mM of the respective forward and reverse primers. PCR products were purified before they were used in the transcription reactions. All primers are listed in Table S1 .
Primer combination for the preparation of the gapB sRNA-like 5 0 -terminal fragment used in Figures S4B and S4C : Fwd-gapB/ Rev-gapB.
Primer combination for the preparation of the ctc sRNA-like 5 0 -terminal fragment used in Figures S4B and S4D : Fwd-ctc/Rev-ctc. Primer combination for the preparation of the veg mRNA used in Figures 2A, 2C , 2D, and S5A: Fwd-veg/Rev2-veg. For the preparation of veg templates with mutated À1 promoter position, the native veg PCR product (amplified with the primer Fwd-veg/ Rev2-veg) was phosphorylated using T4 polynucleotide kinase (Thermo Scientific) and 1 mM ATP following the manufacturer's instructions. The phosphorylated PCR product was ligated with linearized (EcoRV (NEB)) and dephosphorylated (alkaline phosphatase (Thermo Scientific)) pDisplay-AP-CFP-TM (Addgene plasmid #20861; pDisplay-AP-CFP-TM was a gift from Alice Ting (Howarth et al., 2005) ) and transformed into E. coli DH5a. The resulting plasmid pDisplay-AP-CFP-TM-veg-1T was sequenced and used as template for the introduction of the À1 promoter mutations by site-directed mutagenesis. Table S2 lists the primer, the template, the final plasmids and PCR products.
The resulting linearized plasmids pDisplay-AP-CFP-TM-veg-1X (X = A, G, C) were self-ligated using T4 DNA ligase, sequenced and used as templates, together with pDisplay-AP-CFP-TM-veg-1T, to produce the final PCR products, PCRp-veg-1X (X = A, T, G, C) with the primer Fwd-veg/Rev2-veg.
Primer combination for the preparation of the ywjC mRNA used in Figures S5D and S5F-S5H: Fwd-ywjC/Rev-ywjC. The 5 0 end of ywjC mRNA was previously reported to start with a uridine (Price et al., 2001) , but this assignment is likely incorrect for methodological reasons (RT-RACE with poly(A) tailing, followed by removal of all As before mapping to the genome). The preparation of the ywjC templates with mutated À1 promoter positions was performed as described for veg. Table S3 lists the primer, the template, the final plasmids, and the PCR products.
The resulting linearized plasmids pDisplay-AP-CFP-TM-ywjC-1X (X = A, G, C) were self-ligated using T4 DNA ligase, sequenced, and used as templates, together with pDisplay-AP-CFP-TM-ywjC-1T, to produce the final PCR products, PCRp-ywjC-1X (X = A, T, G, C) with the primer Fwd-ywjC/Rev-ywjC.
In vitro transcription with B. subtilis RNAP: run-off transcription assays For the reactions shown in Figures 2A and S4B , 6-10 ng/ml linear template was mixed with 0.15 mM core RNAP in transcription buffer along with 0.4 mM GTP, CTP, UTP, 0.2 mM ATP and 0.5 mCi/ml reaction 32 P-NAD (800 Ci/mmol, Perkin Elmer). 1 mCi/ml reaction g-32 P-ATP (3000 Ci/mmol, Hartmann Analytic) replaced the 32 P-NAD in reactions shown in Figure S5D . In addition, as indicated 0.75 mM sigma factor A or 0.75 mM sigma factor B were added. The reaction mixture was incubated at 37 C for 10 min to 2 h to allow product formation. Samples were taken at the indicated time points, reactions were stopped by the addition of gel loading buffer and analyzed on PAgels (8% or 10% PA, depending on the size of the RNA). Reactions shown in Figures 2C and S5F were performed as described above, but in presence of 0.6 mCi/ml reaction a-32 P-ATP (3,000 Ci/mmol, Hartmann Analytic) as the radioactive nucleotide. The reaction mixture was incubated at 37 C for 30 min (veg), or 5 min (ywjC), respectively, for product formation. Equal amounts of NAD (0.4 mM), or a four-fold excess (0.8 mM), to ATP were added as indicated for the reactions shown in Figures 2D, 3C, 3E , S4C, S4D, S5A, S5G, and S5H. The reaction mixtures were incubated at 37 C as before, or for 60 min (gapB and ctc) to allow product formation. For the reactions shown in Figures 3C and 3E , RNAP, RNAP-rpoB-H482Y, and RNAP-rpoB-Q469I (0.15 mM, each) were used. The reaction mixtures containing NAD-RNA were analyzed on APBgels (5% acrylamide and 0.4% APB for veg and ywjC; 6% acrylamide and 0.5% APB for gapB and ctc). For the verification of the NAD incorporation, aliquots of the in vitro transcription reactions were treated by E. coli NudC (2 mM) in presence of Mg-buffer (25 mM Tris-HCl pH7.5, 50 mM NaCl, 50 mM KCl, 10 mM MgCl 2 , 10 mM DTT) at 37 C for 30 min. RNA Century Marker (Thermo Scientific) was used to estimate the size of the RNA where indicated.
BsRppH and RNase J1 cleavage assays
For the reactions shown in Figures 4B , 5B, 5D, and S7C in vitro BsRppH cleavage assays of in vitro transcribed, radiolabeled (bodylabeled) NAD-RNA were performed in manganese (Mn
2+
) buffer (50 mM Tris-HCl pH 7.5, 0.1 mM MnCl 2 (Sigma-Aldrich), 10 mM DTT, 40 U RiboLock RNase Inhibitor (Thermo Scientific)), 0.1 mM RNA and 0.2 mM BsRppH (mutant) or 0.2 mM RppH (NEB) (or as indicated) at 37 C for 30 min. 5 0 -labeled ppp-RNA replaced the NAD-RNA in the reaction shown in Figure S6C and reaction products were resolved by polyethyleneimine (PEI)-cellulose thin-layer chromatography (Sigma-Aldrich) in 0.3 M LiCl/1 M formic acid. Reactions using E. coli NudC were performed as described above. For the reaction in Figure 6A , additionally 0.1 mM NAD or 1 mM NAD were added to the reaction mixture. Reactions shown in Figure S6A were performed in presence of 0.01 mM BsRppH and 0.5 mM NAD-(bodylabeled) or 0.5 mM ppp-RNA (5 0 -labeled) in manganese or magnesium (Mg 2+ ) buffer (MgCl 2 (Sigma-Aldrich) replaced MnCl 2 ) at 37 C for 30 (120) min. For the reaction in Figures 4A, 4D , and S6D radiolabeled NAD-RNA ( 32 P-NAD, 800 Ci/mmol, Perkin Elmer) was incubated in Mg-, or manganese buffer (2 mM MnCl 2 ), 4 mM RNA and 1 mM BsRppH (mutant), RppH (NEB) or NudC, respectively, at 37 C for 30 min. Aliquots of the reaction were treated in 50 mM NH 4 -acetate pH 5.5 with 0.1 U/ml Nuclease P1 (Sigma-Aldrich) at 37 C for 30 min with subsequent incubation at 70 C for 10 min. Reaction products were resolved by PEI-cellulose thin-layer chromatography in 1 M NH 4 -acetate pH5.5/ ethanol (ratio 4:6). For the reactions shown in Figure S7H , 0.01 mM 32 P-NAD was spiked into 1 mM NAD in Mg-, or manganese buffer (2 mM MnCl 2 ) and treated with 0.2 mM BsRppH (mutant), or 2 mM NudE (-E99Q) at 37 C for 30 min. TLC analysis was performed as described above. For the reactions shown in Figure 7A , in vitro RNase J1 cleavage assays of in vitro transcribed, radiolabeled ppp-, NAD-, and p-RNA (bodylabeled, or 5 0 -labeled (p-RNA)) were performed in J1 buffer (20 mM Tris pH 6.8, 8 mM MgCl 2 , 100 mM NH 4 Cl, 0.1 mM DTT), 0.05 mM RNA and 0.5 mM RNase J1 (-H76A) at 37 C for 10 min.
QUANTIFICATION AND STATISTICAL ANALYSIS Quantification
PAgel, APBgel, TLC and Northern blot intensities were quantified by using ImageQuant software (GE Healthcare).
Statistical analysis
Mean values (n = 3; n = 2 for qPCR analysis) and standard deviations are provided in Figures 1F, 2C , 2D, 3B, 3D, 3E, 4C , 5C, 5E, 7B, S1D, S4E, S5B, S5F-S5H, S6B, S7E, and S7G. Student's t test (p < 0.07, unpaired) was performed for Figure 1B (for the mRNA fraction). Welch's t test (one tailed) was performed for Figures 2D, S5B , S5G, and S5H. LC/MS analysis of small-molecule fractions were performed in biological duplicates or triplicates (mean values and standard deviations are given in the text).
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